Czechia· CZ-0290492
ABRYSVO
A respiratorisches-synzytial-virus impfstoffe product containing rsv (respiratory syncytial virus) subgroup a stabilised prefusion f antigen + rsv (respiratory syncytial virus) subgroup b stabilised prefusion f antigen, registered in Czechia by Pfizer Europe MA EEIG, Bruxelles. The same ATC class is registered in 11 of our 19 countries.
Checked against SÚKL (Czech Republic) on
Informational only — not a medical device.
Where it is registered
Respiratorisches-synzytial-virus impfstoffe is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BX05 (respiratorisches-synzytial-virus impfstoffe), each read from that country’s own register.
- This record: Czechia, from SÚKL (Czech Republic)
- 7 of them publish a price we can compare per daily dose
Respiratorisches-synzytial-virus impfstoffe · ATC J07BX05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
SÚKL (Czech Republic)- Active substance
- RSV (RESPIRATORY SYNCYTIAL VIRUS) SUBGROUP A STABILISED PREFUSION F ANTIGEN + RSV (RESPIRATORY SYNCYTIAL VIRUS) SUBGROUP B STABILISED PREFUSION F ANTIGEN
- Manufacturer
- Pfizer Europe MA EEIG, Bruxelles
- Country
- Czechia (CZ)
- ATC code
- J07BX05
- ATC class
- Respiratorisches-Synzytial-Virus Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- SÚKL (Czech Republic)
- Last checked
- September 28, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX05
Respiratorisches-synzytial-virus impfstoffe, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bcda748a-9103-4566-acfa-0eba68a88c4e GET /v1/drugs/bcda748a-9103-4566-acfa-0eba68a88c4e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "INJ PLQ SOL CVD",
"source": "sukl",
"strength": null,
"pack_size": "10+10X2ML",
"substance": "RSV (RESPIRATORY SYNCYTIAL VIRUS) SUBGROUP A STABILISED PREFUSION F ANTIGEN + RSV (RESPIRATORY SYNCYTIAL VIRUS) SUBGROUP B STABILISED PREFUSION F ANTIGEN",
"cz_kod_sukl": "0290492",
"product_type": "IM/BT",
"substance_codes": "3251,3252",
"registration_state": "R",
"registration_number": "EU/1/23/1752/009"
}See everything about respiratorisches-synzytial-virus impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.